AzTrials
AzTrials

PrematurityNCT05765136

Care Outcomes in Preterm Infants Following the Implementation of Family-centered Interventions

An observational study of Prematurity, run by University of Turku at 1 site in Finland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The proposed study evaluates the effects of two family-centered interventions on the length of stay and outpatient visits and growth of preterm infants.The interventions are 1) the Close Collaboration with Parents training for the staff and 2) moving from traditional neonatal intensive care unit architecture to… Read more about this study

Who is it for?
Any age
Conditions the study is for
Prematurity
How many people
30,000 participants
Where
1 siteFinland
Study dates
1 Sep 2021to May 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Complete preterm birth cohort included in the national Medical Birth Register

Who may be able to join

  • Preterm infants (gestational age <35 weeks) born in Finland between 2006 and 2020

Who cannot join

  • Missing data on key variables (gestational age, place of birth, length of stay)

Trial locations and contacts

1 site in 1 country.

Kjell Helenius, MD, PhD contact

+358405597347

kkhele@utu.fi

Finland1 site, 1 recruiting
  • University of Turku

    Turku, 20521

    Liisa Lehtonen, Professor, +35823130253, lianle@utu.fi

    Kjell Helenius, MD, PhD, +35823133422, kkhele@utu.fi

    Recruiting

Other trials in Finland

About this study

Official title: The Effects of the Close Collaboration With Parents Training and Single-family Room Architecture on the Length of Stay and Growth Parameters of Preterm Infants - a National Multicenter Study in Finland

The proposed study evaluates the effects of two family-centered interventions on the length of stay and outpatient visits and growth of preterm infants.The interventions are 1) the Close Collaboration with Parents training for the staff and 2) moving from traditional neonatal intensive care unit architecture to single-family room architecture.

Read the detailed description

The Close Collaboration with Parents training targeted to the health care team of neonatal intensive care units to facilitate parental involvement in infant care and to support parenting. The training program involves a structured education process, where trained mentors educate staff in neonatal units. The duration of the training program is 18 months per unit. The training program has been implemented in eleven neonatal units in Finland since 2009; another 12 units haver not gone through the training.

The other intervention, single-family room architecture, provides facilities for parents to stay in the room of their infant throughout there 24 hour day. This intervention has been carried out in four neonatal units in Finland since 2014; in one by restructuring the existing unit, and in three by building a new unit/hospital.

In this study, the investigators are going to use national, population-based registers (the Medical Birth Register, the small Preterm Infant Register and the Hospital Discharge Register) governed by the Finnish National Institute for Health and Welfare. These registers have been widely used for observational studies, and contain data on all newborn infants in the country.

There are currently 23 neonatal units in Finland. Three units have undergone both interventions, nine units have undergone one intervention, and 12 units have undergone neither. Preterm infants (born before 35 gestational weeks) discharged from any unit will be divided into those who have been cared for all, part or no time in a hospital with an intervention, separately for each intervention. The outcome measures of interest will be related to health care utilization such as the length of stay and unscheduled outpatient visits, and to clinical outcomes such as postnatal growth parameters.

Conditions
Prematurity
Keywords
Infant, preterm, Length of stay, Neonatal intensive care, Postnatal growth
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05765136
Study groupRoleWhat they receive
Close collaboration groupPreterm infants born in hospitals where the Close Collaboration with Parents training program has been successfully implemented
Single-family room groupPreterm infants born in hospitals that have implemented an architectural change to single-family room design
Control groupPreterm infants born in hospitals that have not gone through any of the two aforementioned interventions (single-family room architecture or Close Collaboration with Parents training program)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Length of stay

    The length in days on the initial hospitalization following preterm birth

    Measured: Immediately after discharge

Secondary outcomes (6)
  1. Weight

    Kilograms

    Measured: Immediately after discharge

  2. Length

    Centimeters

    Measured: Immediately after discharge

  3. Head circumference

    Centimeters

    Measured: Immediately after discharge

  4. Postnatal emergency visits

    Amount of unplanned emergency outpatient visits after discharge from initial hospitalization

    Measured: Within the first year of life (corrected gestational age) after discharge home

  5. Postnatal emergency hospitalizations

    Duration of unplanned emergency outpatient hospitalizations after discharge from initial hospitalization

    Measured: Within the first year of life (corrected gestational age) after discharge home

  6. Gestational age at discharge

    The corrected gestational age of the infant at final discharge from neonatal care

    Measured: Immediately after discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Mar 2023
  2. Study start1 Sep 2021
  3. Primary completionMay 2023 (estimated)
  4. Study completionMay 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
30,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05765136
Sponsor's protocol ID
VVM_LOS_2021
Status last verified
Feb 2023
First submitted
1 Sep 2021
Last updated
13 Mar 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Prematurity, run by University of Turku at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Kjell Helenius, MD, PhD (+358405597347, kkhele@utu.fi), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Length of stay (time frame: Immediately after discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in